Business Context and Reporting Period
This Form 8-K Current Report was filed by Lifeward Ltd. on August 14, 2026, with events reported through August 20, 2026. The filing details significant changes to the composition of the Company's Board of Directors.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The primary material change reported is the restructuring of the Board of Directors:
- Appointments: On August 14, 2026, Yonason Greenwald and Haggai Zamir were appointed as Class III Directors. On August 20, 2026, Avraham Gabay was appointed as a Class III Director and Chair of the Board.
- Resignation: On August 20, 2026, Nadav Kidron resigned from the Board effective immediately. The Company stated this departure was not due to any disagreement regarding operations, policies, or practices.
- Committee Assignments: Mr. Greenwald joined the Audit, Compensation, and Nominating and Corporate Governance Committees. Mr. Zamir joined the Nominating and Corporate Governance Committee.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, or management commentary regarding future financial performance. No specific risks or contingencies were disclosed in this report. The Company confirmed there are no undisclosed transactions or family relationships involving the new directors that require disclosure under Item 404(a) of Regulation S-K.
Key Facts for Investor Verification
- Verify the specific committee roles and voting rights of the newly appointed directors (Greenwald, Zamir, Gabay).
- Confirm the effective date of Nadav Kidron's resignation and any potential impact on board quorum or committee composition.
- Review the Company's most recent Form 10-K (filed March 18, 2026) to understand the standard compensation package applicable to the new non-employee directors.
- Monitor upcoming shareholder meetings to confirm the ratification of these appointments at the 2026 Annual Meeting of Shareholders.